Portal vein embolization: what do we know?

Détails

Ressource 1Télécharger: serval:BIB_A5C4F61C4C81.P001 (299.48 [Ko])
Etat: Public
Version: de l'auteur
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_A5C4F61C4C81
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Portal vein embolization: what do we know?
Périodique
Cardiovascular and Interventional Radiology
Auteur(s)
Denys A., Prior J., Bize P., Duran R., De Baere T., Halkic N., Demartines N.
ISSN
1432-086X (Electronic)
ISSN-L
0174-1551
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
35
Numéro
5
Pages
999-1008
Langue
anglais
Notes
Publication types: Journal Article Publication Status: ppublish. PDF type: REVIEW ARTICLE
Résumé
Portal vein embolization (PVE) has been developed to increase the size of the future remnant liver (FRL) left in place after major hepatectomy, thus reducing the risk of postoperative liver insufficiency. PVE consist in embolizing preoperatively portal branches of the segments that will be resected. Indication is based on preoperative measurements of the FRL by computed tomography and its ratio with either the theoretical liver volume or by direct measurement of the functional liver volume. After PVE, the volume and function of the FRL increases in 3 to 6 weeks, permitting extensive resections in patients otherwise contraindicated for liver resection. The PVE technique is variable from one center to another; however n-butyl-cyano-acrylate provides an interesting compromise between hypertrophy rate and procedure risk.
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/03/2012 16:08
Dernière modification de la notice
01/10/2019 6:19
Données d'usage